Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients.

Autor:	Nathan R; Division of Gerontology, Geriatrics, and Palliative Medicine, 12264University of Maryland School of Medicine, Baltimore, MD, USA., Mupamombe CT; 53422West Virginia University School of Medicine, Ruby Memorial Hospital, Buffalo, NY, USA., Elibol J; 12291Palliative Care Fellowship,University of Buffalo Jacobs School of Medicine, Buffalo, NY, USA., Case AA; Department of Supportive and Palliative Care, 2074Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine at the University of Buffalo, Buffalo, NY, USA., Smith D; Department of Health Behavior, 2074Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Hyland A; Department of Health Behavior, 2074Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Attwood K; Department of Biostatistics and Bioinformatics, 2074Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Hansen ED; Department of Supportive and Palliative Care, 2074Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine at the University of Buffalo, Buffalo, NY, USA.
Jazyk:	angličtina
Zdroj:	The American journal of hospice & palliative care [Am J Hosp Palliat Care] 2023 Apr; Vol. 40 (4), pp. 368-373. Date of Electronic Publication: 2022 Jun 24.
DOI:	10.1177/10499091221110217
Abstrakt:	Objectives: Our study sought to further characterize patterns of medical cannabis use in elderly cancer patients. Furthermore, we sought to assess efficacy of medical cannabis for the treatment of pain, nausea, anorexia, insomnia and anxiety in elderly cancer patients. Background: Medical cannabis use is growing for symptom management in cancer patients, but limited data exists on the safety or efficacy of use in elderly patients. Methods: A retrospective chart review assessing changes in numerical symptom scores reported at clinic visits before and after medical cannabis initiation. Results: There was no statistically significant difference in pain, nausea, appetite, insomnia or anxiety scores reported before and after initiation of medical cannabis. Oil was the most common form used, followed by vape, and the most common ratios used were high tetrahydrocannabinol (THC) to cannabidiol (CBD) and equal parts THC/CBD products. Conclusion: This study did not find a statistically significant change in symptom scores with medical cannabis use, although further study is warranted given the limitations of the present study. Elderly patients most commonly are using equal parts THC/CBD or high THC ratio products initially.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu